Here, patients with high urinary CD80 had a good response to immunosuppressive therapy and a significantly lower risk of progressing to CKD, possibly underlining the differentiation between MCD and FSGS [14]. This evidence concerns the gene CD80 and focal segmental glomerulosclerosis.